中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2015年
26期
40-40,42
,共2页
幽门螺杆菌%阿莫西林%呋喃唑酮%四环素
幽門螺桿菌%阿莫西林%呋喃唑酮%四環素
유문라간균%아막서림%부남서동%사배소
Helicobacter pylori%Amoxicillin%Furazolidone%Tetracycline
目的：探讨新四联疗法治疗幽门螺杆菌(Hp)感染的有效性和安全性。方法：收治Hp阳性胃、十二指肠溃疡患者60例，随机分为两组，各30例，A组应用雷贝拉唑+枸橼酸铋钾+阿莫西林+呋喃唑酮治疗，B组应用雷贝拉唑+枸橼酸铋钾+四环素+呋喃唑酮治疗，比较两组治疗效果。结果：两组Hp根除率分别为93.33%和96.66%。结论：新四联疗法治疗Hp感染初治根除率高，不良反应少。
目的：探討新四聯療法治療幽門螺桿菌(Hp)感染的有效性和安全性。方法：收治Hp暘性胃、十二指腸潰瘍患者60例，隨機分為兩組，各30例，A組應用雷貝拉唑+枸櫞痠鉍鉀+阿莫西林+呋喃唑酮治療，B組應用雷貝拉唑+枸櫞痠鉍鉀+四環素+呋喃唑酮治療，比較兩組治療效果。結果：兩組Hp根除率分彆為93.33%和96.66%。結論：新四聯療法治療Hp感染初治根除率高，不良反應少。
목적：탐토신사련요법치료유문라간균(Hp)감염적유효성화안전성。방법：수치Hp양성위、십이지장궤양환자60례，수궤분위량조，각30례，A조응용뢰패랍서+구연산필갑+아막서림+부남서동치료，B조응용뢰패랍서+구연산필갑+사배소+부남서동치료，비교량조치료효과。결과：량조Hp근제솔분별위93.33%화96.66%。결론：신사련요법치료Hp감염초치근제솔고，불량반응소。
Objective:To explore the effectiveness and safety of new quadruple therapy for helicobacter pylori infection.Methods:60 patients with gastric,duodenal ulcer and positive Hp were selected.They were randomly divided into two groups with 30 cases in each.A group was treated with rabeprazole plus bismuth potassium citrate plus amoxicillin plus furazolidone.B group was treated with rabeprazole plus bismuth potassium citrate plus tetracycline plus furazolidone.We compared the therapeutic effect of the two groups.Results:Eradication rate of two groups were 93.33% and 96.66% respectively.Conclusion:Eradication rate of new quadruple therapy for HP infection was high,and adverse reactions was little.
